A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/5377 (2006.01) A61P 9/10 (2006.01)
Patent
CA 2562287
The present invention is applicable in the pharmaceutical industry and relates to the use of molsidomine or a pharmaceutically acceptable salt thereof, particularly in the form of a sustained-release solid oral composition effective for 24 hours, for producing a drug for preventing or controlling atherosclerosis.
La présente invention qui trouve application dans le domaine de l'industrie pharmaceutique a pour objet l'utilisation de la molsidomine ou de l'un de ses sels pharmaceutiquement acceptables, notamment sous la forme d'une composition orale solide ô libération prolongée efficace pendant 24 heures, pour la fabrication d'un médicament destiné ô prévenir ou diminuer le développement de l'athérosclérose.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Therabel Pharmaceuticals Limited
LandOfFree
Sustained-release oral molsidomine composition for treating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained-release oral molsidomine composition for treating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained-release oral molsidomine composition for treating... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1585417